PH15417A - 1-benzazolylaleyl-4-substituted piperidines - Google Patents

1-benzazolylaleyl-4-substituted piperidines

Info

Publication number
PH15417A
PH15417A PH18950A PH18950A PH15417A PH 15417 A PH15417 A PH 15417A PH 18950 A PH18950 A PH 18950A PH 18950 A PH18950 A PH 18950A PH 15417 A PH15417 A PH 15417A
Authority
PH
Philippines
Prior art keywords
benzazolylaleyl
substituted piperidines
piperidines
substituted
Prior art date
Application number
PH18950A
Other languages
English (en)
Inventor
Jan Vandenberk
Ludo E J Kennis
Der Aa Marcel J M C Van
Albert H N Th Heertum
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PH15417A publication Critical patent/PH15417A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PH18950A 1975-10-08 1976-09-28 1-benzazolylaleyl-4-substituted piperidines PH15417A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62072775A 1975-10-08 1975-10-08
US05/713,309 US4035369A (en) 1975-10-08 1976-08-10 1-Benzazolylalkyl-4-substituted-piperidines

Publications (1)

Publication Number Publication Date
PH15417A true PH15417A (en) 1983-01-07

Family

ID=27088773

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18950A PH15417A (en) 1975-10-08 1976-09-28 1-benzazolylaleyl-4-substituted piperidines

Country Status (31)

Country Link
US (1) US4035369A (ja)
JP (1) JPS5246082A (ja)
AT (1) AT365185B (ja)
AU (1) AU511834B2 (ja)
BG (1) BG27542A3 (ja)
CA (1) CA1085853A (ja)
CH (1) CH630915A5 (ja)
CS (1) CS225101B2 (ja)
DE (1) DE2645125A1 (ja)
DK (1) DK151801C (ja)
EG (1) EG12969A (ja)
ES (1) ES452200A1 (ja)
FI (1) FI63228C (ja)
FR (1) FR2346009A1 (ja)
GB (1) GB1532546A (ja)
GR (1) GR61672B (ja)
HU (1) HU174927B (ja)
IE (1) IE43951B1 (ja)
IL (1) IL50631A (ja)
IT (1) IT1069293B (ja)
LU (1) LU75954A1 (ja)
NL (1) NL7611085A (ja)
NO (1) NO144926C (ja)
NZ (1) NZ182134A (ja)
PH (1) PH15417A (ja)
PL (1) PL106815B1 (ja)
PT (1) PT65688B (ja)
RO (1) RO69904A (ja)
SE (1) SE417610B (ja)
SU (1) SU663306A3 (ja)
YU (1) YU39976B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
EP0034116A3 (en) * 1980-02-11 1981-09-02 Berlex Laboratories, Inc. N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
DE3442757A1 (de) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR2702214B1 (fr) * 1993-03-05 1995-04-14 Adir Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
ATE247114T1 (de) 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
GB9613423D0 (en) * 1996-06-26 1996-08-28 Lilly Industries Ltd Pharmaceutical compounds
JP2010503722A (ja) * 2006-09-19 2010-02-04 シプラ・リミテッド シクレソニドとその結晶変異体の調製方法
CN101759693B (zh) * 2008-12-23 2011-09-14 江苏恩华药业股份有限公司 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用
EP4308119A1 (en) * 2021-03-19 2024-01-24 Centre National de la Recherche Scientifique <sup2/>? <sub2/>?7?applications of biased ligands of the serotonin 5-htreceptor for the treatment of pain, multiple sclerosis and the control of thermoregulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (ja) * 1962-06-13
US3225052A (en) * 1964-05-06 1965-12-21 Janssen Pharmaceutica Nv Benzimidazolinyl piperidine derivatives
FR1573739A (ja) 1968-07-26 1969-07-04
US3647790A (en) * 1969-04-08 1972-03-07 American Home Prod Ouinoxalinyl-oxazolidines and -oxazines

Also Published As

Publication number Publication date
NO144926B (no) 1981-08-31
IE43951B1 (en) 1981-07-01
NZ182134A (en) 1979-01-11
PL106815B1 (pl) 1980-01-31
HU174927B (hu) 1980-04-28
AU1807876A (en) 1978-04-06
NO144926C (no) 1981-12-09
FI762865A (ja) 1977-04-09
BG27542A3 (en) 1979-11-12
YU39976B (en) 1985-06-30
GR61672B (en) 1978-12-05
ES452200A1 (es) 1978-01-16
SE417610B (sv) 1981-03-30
IT1069293B (it) 1985-03-25
AU511834B2 (en) 1980-09-11
NL7611085A (nl) 1977-04-13
RO69904A (fr) 1980-08-15
LU75954A1 (ja) 1977-05-09
DK151801B (da) 1988-01-04
ATA745276A (de) 1981-05-15
IL50631A0 (en) 1976-12-31
EG12969A (en) 1981-03-31
AT365185B (de) 1981-12-28
DE2645125C2 (ja) 1988-11-24
JPS6215553B2 (ja) 1987-04-08
US4035369A (en) 1977-07-12
CH630915A5 (de) 1982-07-15
YU248076A (en) 1983-01-21
FR2346009A1 (fr) 1977-10-28
IL50631A (en) 1980-02-29
FI63228C (fi) 1983-05-10
JPS5246082A (en) 1977-04-12
DK452076A (da) 1977-04-09
FR2346009B1 (ja) 1978-12-22
DK151801C (da) 1988-06-06
FI63228B (fi) 1983-01-31
PT65688A (en) 1976-11-01
IE43951L (en) 1977-04-08
PL192890A1 (pl) 1978-03-28
CA1085853A (en) 1980-09-16
CS225101B2 (en) 1984-02-13
DE2645125A1 (de) 1977-04-21
NO763424L (ja) 1977-04-13
PT65688B (en) 1978-04-02
SE7611137L (sv) 1977-04-09
GB1532546A (en) 1978-11-15
SU663306A3 (ru) 1979-05-15

Similar Documents

Publication Publication Date Title
GB1516780A (en) Piperidine derivatives
JPS51104954A (en) Kaihokanoni kumiawaseta sokuhoreerutoyokobotoojusuru betsudofureemu
GB1519080A (en) Dibenzocycloheptenylidene piperidines
PH15417A (en) 1-benzazolylaleyl-4-substituted piperidines
JPS51100833A (en) Nanshikyakyubooruno seizohoho
GB1519107A (en) Thioxanthen-9-ylidene piperidines
JPS51108884A (en) x senkaisetsusokuteisochi
AU1105976A (en) 5-nitrothiazolylimidazolidine
CS189776A2 (en) Zpusob regenerace paladiovych katalyzatoru
JPS5191391A (en) Hatsukohonyoru ll isoroishinno seizoho
JPS5197393A (en) x senshutsuryokuno seigyohoho
JPS5186992A (en) x sensochi
JPS51104784A (en) Jitenshano ritsutaichushasochi
JPS51103769A (en) Handotaisochino seizohoho
JPS51102182A (en) Netsuseikeikanona fushokufu
JPS5191393A (en) Hatsukohonyoru ll hisuchijinnoseizoho
JPS5179783A (en) ll ringosanno seizohoho
JPS5195185A (en) Hatsukohonyoru ll gurutaminsannoseizoho
JPS51101586A (en) X senkensasochi
JPS51104888A (en) x senbunsekisochi
JPS51105285A (en) Kaitentaiinkyoku x senkan
JPS51103492A (en) x senbunsekisochino sokuteihetsudo
JPS5198075A (en) Sosagata x senkaisetsukenbihokamera
JPS5183491A (en) x sensochi
JPS5197392A (en) x senshutsuryokuno seigyohoho